SCHEMBL21653691

SCHEMBL21653691

Cn1nc2ccc(N)c(F)c2c1Cl

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26156075 0.84 ALDH1A1 (0.32) PTPN11
SCHEMBL21653695 0.82 PTPN11 (0.35) PTPN11
SCHEMBL21631391 0.79 HTR1A (0.34) PTPN11
SCHEMBL21653692 0.79 PTPN11 (0.31) PTPN11
SCHEMBL21653795 0.73 LPL (0.32) —
SCHEMBL23508727 0.69 PTPN11 (0.34) PTPN11
SCHEMBL19489400 0.69 PTPN11 (0.33) PTPN11
SCHEMBL23683058 0.68 PTPN11 (0.33) PTPN11
SCHEMBL21631683 0.68 PTPN11 (0.33) PTPN11
SCHEMBL23229326 0.67 PTPN11 (0.32) PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021149817-A1 Enhancement of anti-tumor activity of SHP2 inhibitor pyrimidinone in combination with novel cancer medicines in cancers TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-07-29 — — WO disclosed
WO-2020022323-A1 HETEROBICYCLIC COMPOUNDS FOR INHIBITING THE ACTIVITY OF SHP2 TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-01-30 — — WO disclosed
Send feedback